Gastric electrical pacing in morbidly obese patients altered gut peptide levels (CCK, somatostatin) and reduced leptin, providing a hormonal mechanism for the satiety and weight loss observed with this device.
Hormonal mechanismGastric pacing changed appetite hormone levels — it works through the gut's peptide signaling system, not just by making the stomach smaller
What the researchers found
Gastric pacing in morbidly obese patients altered circulating CCK, somatostatin, and leptin levels, providing a neuroendocrine mechanism for the satiety and weight loss effects of this device.
Why it matters
Understanding that gastric pacing works through hormones, not just mechanics, opens the door to optimizing the electrical parameters for maximal appetite-suppressing peptide release.
How the study worked
Clinical trial measuring plasma gut peptides (CCK, somatostatin, GLP-1, PYY) and leptin in morbidly obese patients before and during gastric electrical pacing treatment.
What this study cannot tell us
Small clinical study. Cause-effect relationship between peptide changes and weight loss not definitively established. The specific pacing parameters affecting each peptide not characterized.
How to read the evidence
Moderate evidence from a clinical study with objective hormonal measurements in treated patients.
When this study was published
Published in 2003. Gastric electrical stimulation for obesity continues to be developed with improved understanding of its hormonal effects.
The bigger picture
Electrical stimulation of the gut can modulate appetite hormones — a concept that bridges neurostimulation and endocrinology for obesity treatment.
Questions still open
- Can pacing parameters be optimized for maximal GLP-1/PYY release?
- Does the hormonal response predict weight loss success?
- Could non-invasive gastric stimulation achieve similar peptide changes?
Common questions
How does a stomach pacemaker help with weight loss?
Is this different from gastric bypass?
Read the original research
Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.
Obesity research, 11(12), 1456-62
Citation
Cigaina, Valerio; Hirschberg, Angelica L. (2003). Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.. Obesity research, 11(12), 1456-62.